Interfering with bromodomain epigenome readers as therapeutic option in mucoepidermoid carcinoma

Interfering with bromodomain epigenome readers as therapeutic option in mucoepidermoid carcinoma

Renata L. Markman, Liana P. Webber, Carlos H. V. Nascimento Filho, Leonardo A. Reis, Pablo A. Vargas, Marcio A. Lopes, Virgilio Zanella, Manoela D. Martins, Cristiane H. Squarize, Rogerio M. Castilho

ARTIGO

Inglês

Agradecimentos: This work was conducted during a visiting scholar period at the University of Michigan, sponsored by the Capes Foundation within the Ministry of Education, Brazil (grant n. BEX / 88881.132606/2016-01 PDSE). This grant was funded by a University of Michigan School of Dentistry faculty...

Abstract: Emerging evidence indicates that bromodomains comprise a conserved class of epigenome readers involved in cancer development and inflammation. Bromodomains are associated with epigenetic modifications of gene transcription through interactions with lysine residues of histone tails....

COORDENAÇÃO DE APERFEIÇOAMENTO DE PESSOAL DE NÍVEL SUPERIOR - CAPES

Fechado

Interfering with bromodomain epigenome readers as therapeutic option in mucoepidermoid carcinoma

Renata L. Markman, Liana P. Webber, Carlos H. V. Nascimento Filho, Leonardo A. Reis, Pablo A. Vargas, Marcio A. Lopes, Virgilio Zanella, Manoela D. Martins, Cristiane H. Squarize, Rogerio M. Castilho


										

Interfering with bromodomain epigenome readers as therapeutic option in mucoepidermoid carcinoma

Renata L. Markman, Liana P. Webber, Carlos H. V. Nascimento Filho, Leonardo A. Reis, Pablo A. Vargas, Marcio A. Lopes, Virgilio Zanella, Manoela D. Martins, Cristiane H. Squarize, Rogerio M. Castilho

    Fontes

    Cellular oncology

    Vol. 42, no. 2 (Apr., 2019), p. 143-155